^(131)I治疗分化型甲状腺癌健康科普的研究进展  

Research progress of health science popularization in the treatment of differentiated thyroid carcinoma with ^(131)I

作　　者：王燕[1,2] 施冰梓 杨素云[2] Wang Yan;Shi Bingzi;Yang Suyun(School of Medical Sciences,Shanxi Medical University,Taiyuan 030001,China;Department of Nuclear Medicine,First Hospital of Shanxi Medical University,Taiyuan 030001,China;School of Nursing,Shanxi Medical University,Taiyuan 030001,China)

机构地区：[1]山西医科大学医学科学院,太原030001 [2]山西医科大学第一医院核医学科,太原030001 [3]山西医科大学护理学院,太原030001

出　　处：《中华现代护理杂志》2023年第30期4190-4195,共6页Chinese Journal of Modern Nursing

基　　金：山西省科技厅科技战略研究专项(202204031401144)。

摘　　要：健康科普是^(131)I治疗分化型甲状腺癌患者取得积极生存结局的关键因素之一,本文就健康科普的概况、^(131)I治疗分化型甲状腺癌健康科普的必要性以及国内外实施现状进行综述,以期为临床实践中开展全面的^(131)I治疗分化型甲状腺癌健康科普工作提供参考。Health science popularization is one of the key factors for patients with differentiated thyroid carcinoma treated with ^(131)I to achieve positive survival outcomes.This paper reviews the general situation of health science popularization,the necessity of health science popularization for differentiated thyroid carcinoma treated with ^(131)I and the current implementation situation at home and abroad,in order to provide reference for comprehensive health science popularization for differentiated thyroid carcinoma treated with 131I in clinical practice.

关 键 词：综述 分化型甲状腺癌 ^(131)I 健康科普 

分 类 号：R473.73[医药卫生—护理学]